case of combination cabozantinib nivolumab for progressive metastatic renal cell carcinoma (mrcc)
Published 3 years ago • 139 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
3:04
fda approves nivolumab plus cabozantinib for advanced renal cell carcinoma
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
2:02
cabozantinib in mrcc
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
6:30
cabozantinib plus nivolumab for first-line mrcc
-
3:53
cabozantinib in combination with immunotherapy for advanced renal cell carcinoma
-
0:55
dr. apolo on the combination of cabozantinib plus nivolumab in urothelial carcinoma
-
0:23
kidney cancer trial (the radical study)
-
3:31
cabozantinib–nivolumab and ipilimumab combinations show potential for gu cancers | andrea apolo
-
2:34
nivo cabozantinib vs sunitinib for first-line treatment of arcc
-
1:35
checkmate-9er shows efficacy of nivolumab/cabozantinib combo in rcc
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
4:22
cabozantinib in combination w/ nivolumab and ipilimumab of imdc intermediate or poor risk signif...
-
3:26
nivolumab and cabozantinib versus standard of care in renal cell carcinoma
-
1:13
potential with frontline cabozantinib plus nivolumab in advanced rcc
-
5:58
checkmate 9er update confirms benefits of nivolumab–cabozantinib in rcc | cristina suárez
-
6:29
what is kidney cancer